Table 1 Patients characteristics
Clinical characteristics | Number (n) | Percent |
|---|---|---|
Total number | 122 | 100 |
Age at diagnosis (years) | ||
Median | 56 | |
Range | 21–79 | |
Gender | ||
Male | 74 | 61 |
Female | 48 | 39 |
Histology | ||
Adenoid cystic | 47 | 38.6 |
Squamous cell | 26 | 21.3 |
Adenocarcinoma | 17 | 13.9 |
Soft tissue sarcoma | 7 | 5.7 |
Melanoma | 6 | 4.9 |
Undifferentiated | 4 | 3.3 |
Other | 15 | 12.3 |
Tumor stage | ||
T1 | 12 | 9.8 |
T2 | 7 | 5.7 |
T3 | 16 | 13.2 |
T4 | 87 | 71.3 |
Primary tumor site | ||
Nasal sinuses | 86 | 70.5 |
Nasal cavity | 36 | 29.5 |
Tumor state at IMRT | ||
Primary diagnosis | 82 | 67.2 |
Recurrence | 40 | 32.8 |
Resection status | ||
R0 | 11 | 9.0 |
R1 | 24 | 19.7 |
R2 | 33 | 27.1 |
Rx | 31 | 25.4 |
No resection | 23 | 18.8 |
Concurrent Systemic therapy | ||
None | 108 | 88.5 |
Chemotherapy | 11 | 9.0 |
Cetuximab | 3 | 2.5 |
RT dose (Gy) | ||
≥ 60 Gy | 87 | 71.3 |
< 60 Gy | 35 | 28.7 |